Concepedia

Publication | Open Access

Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer

135

Citations

22

References

2023

Year

Abstract

ClinicalTrials.gov Identifier: NCT03639948.

References

YearCitations

Page 1